Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

1articles mentioning drugs

3drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: huCART19-IL18 ×

huCART19-IL18

This drug is selected. Its supporting articles are shown below.

huCART19-IL181

Articles mentioning huCART19-IL18

1 articles · page 1 of 1

557 Evaluation of huCART19-IL18 manufactured using Synecta™ CDNP technology to improve CAR-T yield and consistency in cohort D of an ongoing phase I study (NCT04684563)

jitc · abstract · 2025-11-04 · 3 matching annotations

96.6%

huCART19-IL18 chronic lymphocytic leukemia B-cell malignancies non-Hodgkin lymphoma NEJM NEJMoa2408771

…ty. In Cohorts A-C of the ongoing Phase I study ( NCT04684563), huCART19-IL18 exhibited a manageable safety profile and encouraging antitumor…